TradingView

EN English (IN) ENEnglish ENEnglish (UK) DEDeutsch FRFrançais ESEspañol ITItaliano PLPolski SVSvenska TRTürkçe RUРусский PTPortuguês IDBahasa Indonesia MSBahasa Melayu THภาษาไทย VITiếng Việt JA日本語 KO한국어 ZH简体中文 ZH繁體中文 ARالعربية HEעברית

TradingView

Ticker Trading Ideas Educational Ideas Scripts People

Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Sign Out Sign In Go PRO Go PRO 30-day Free Trial Join For Free Go PRO Early

Ideas
Markets
Scripts
Screener
Chart
More

US Stocks Healthcare Biotechnology & Medical Research

ZYNERBA PHARMACEUTICALS, INC. NASDAQ:ZYNE

Open

Volume

1 Day Range

EPS

Mkt Cap

Div Yield

Overview

Ideas Technicals

ZYNE Stock Chart

Ideas

Videos only

consolidating in lower range

ZYNE, D

nalinakshi 16 views ・

The company is currently in Phase II testing of ZYN002 for treatment of refractory epilepsy and osteoarthritis. It’s also in Phase I testing of ZYN002 for treatment of Fragile X syndrome. ZYN001 is still in preclinical testing for multiple indications as well. Shares of ZYNE stumbled at the start of 2017 as the company announced a 2.8 million-share offering ...

Financials

Valuation

Enterprise Value/EBITDA, TTM —

Enterprise Value, FQ —

Market Cap - Basic —

Number of Employees —

Number of Shareholders —

Price/Earnings, TTM —

Price/Revenue, TTM —

Price/Book Ratio, FY —

Price/Sales Ratio, FY —

Balance Sheet

Current Ratio, FQ —

Debt to Equity, FQ —

Net Debt, FQ —

Quick Ratio, FQ —

Total Assets, FQ —

Total Debt, FQ —

Operating Metrics

Return on Assets, TTM —

Return on Equity, TTM —

Return on Invested Capital, TTM —

Revenue per Employee, TTM —

Price History

Average Volume (10 day) —

Beta - 1 Year —

Price - 52 Week High —

Price - 52 Week Low —

Dividends

Dividends Paid, FY —

Dividends per Share, FY —

Expected Annual Dividends —

Dividends Yield —

Margins

Net Margin, TTM —

Gross Margin, TTM —

Operating Margin, TTM —

Pretax Margin, TTM —

Income Statement

Basic EPS, Net Income —

Earnings per Share, Basic, TTM —

EBITDA, TTM —

Gross Profit, FY —

Last Annual EPS —

Last Annual Revenue, FY —

Net Income, FY —

Total Revenue, FY —

Free Cash Flow, TTM —

Profile

News

Community & Tools

House Rules Moderators People Chat Stock Screener Forex Screener Crypto Screener Economic Calendar

For Business

Website & Broker Solutions Widgets Charting Library Trading Terminal Brokerage Integration Advertising Referral Program Content Streams & RSS

Support

Contact Support Status Page Blog Feature Request Security Vulnerability Help & Wiki FAQ Contacts

About

How It Works Features Pricing Press Terms of Use Risk Warning Privacy Policy Cookies Policy

Made with

From the creators of MultiCharts

Select market data provided by ICE Data services

ZYNERBA PHARMACEUTICALS, INC. NASDAQ:​ZYNE